Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.
Widespread synaptic loss in multiple sclerosis.
MAIT cells in autoimmunity, immune mediated diseases and airways disease.
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
The blood-brain barrier in systemic inflammation.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis].
The astrocyte in multiple sclerosis revisited.
Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Comparing statistical methods for removing seasonal variation from vitamin D measurements in case-control studies.
Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling.
Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
Restless leg syndrome and multiple sclerosis: a case-control study in China.
In vivo regulation of gene expression and Th17 differentiation by RORγt inverse agonists.
Neuropsychiatric side-effects of interferon-alpha treatment: pathophysiology and therapeutic options.
Distress improves after mindfulness training for progressive MS: A pilot randomised trial.
Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.
Direction-specific impairments of limits of stability in individuals with multiple sclerosis.
Mitochondrial DNA T4216C and A4917G variations in multiple sclerosis.
Should patients with optic neuritis be treated with steroids?
Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
Abnormalities of the executive control network in multiple sclerosis phenotypes: An fMRI effective connectivity study.
Neuroprotective Effects of Endurance Exercise against High Fat Diet-Induced Hippocampal Neuroinflammation.
H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis.
Pages
« first
‹ previous
…
678
679
680
681
682
683
684
685
686
…
next ›
last »